MB
MAIA Biotechnology, Inc.
SEC filingBiotechnology · Chicago, IL
Amount raised$1.5Msold at filing
Total offering$2M$490K still open
Investors in the raise17count reported to the SEC
FiledJan 5, 2026first sale Dec 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sergei GryaznovExecutive Officer
Jean-Manasse TheageneDirector
Ramiro GuerreroDirector
Stan SmithDirector
Cristian Ngar LuputDirector
Vlad VitocExecutive Officer, Director
Jeffrey HimmelreichExecutive Officer, Director
Steven ChaoukiDirector
Louie Ngar YeeDirector
Executive officers, directors and promoters as listed on the Form D.